Technology | 2020.08.27
NW Bio Accelerating Sawston Plant Phase I Buildout
BETHESDA, Md., Aug. 27, 2020 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the Company is pursuing an intensive program of manufacturing preparations...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]hase-i-buildout-301119755.html
